Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Active substance factsheet - Last updated: 03/01/2024
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2- methylprop-1-enyl)-cyclopropanecarboxy- late (mixture of 4 isomers 1R trans, 1R:1R trans, 1S: 1R cis, 1R: 1R cis,1S 4:4:1:1) (d-Allethrin)
EC number:
687-634-7
CAS number:
231937-89-6
IUPAC name:
2-methyl-4-oxo-3-(prop-2-en-1-yl)cyclopent-2-en-1-yl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate
BAS number:
1237
Product-type:
PT18
Candidate for substitution:
Yes
Regulatory categorisation:
Review programme substance
Approval/Assessment status:
Not approved
No related authorised products are available
Evaluating competent authority:
Germany
R4BP asset number:
-
Start date:
End date:
Assessment Report
Final_AR_public.pdf (en) (17/03/2022)
Final_CAR_public.pdf (en) (30/11/2021)
Final_AR_public.pdf (en) (17/11/2021)
BPC opinions
CZ Minority opinion d-Allethrin_PT_18.pdf (en) (05/11/2021)
d-Allethrin_PT_18_Final_BPC_Opinion.pdf (en) (05/11/2021)
d-Allethrin_PT_18_Final_BPC_Opinion.pdf (en) (05/11/2021)
CZ Minority opinion d-Allethrin_PT_18.pdf (en) (05/11/2021)
Evaluating competent authority:
Germany
Assessment outcome:
Not successful
Conclusion date:
21/03/2023
Assessment Report
Final_CAR_public.pdf (en) (30/11/2021)
Final_AR_public.pdf (en) (17/11/2021)
BPC opinions
CZ Minority opinion d-Allethrin_PT_18.pdf (en) (05/11/2021)
d-Allethrin_PT_18_Final_BPC_Opinion.pdf (en) (05/11/2021)
Evaluating competent authority:
Germany
Assessment outcome:
Not successful
Conclusion date:
21/03/2023
Assessment Report
Final_AR_public.pdf (en) (17/03/2022)
BPC opinions
d-Allethrin_PT_18_Final_BPC_Opinion.pdf (en) (05/11/2021)
CZ Minority opinion d-Allethrin_PT_18.pdf (en) (05/11/2021)